UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects

International journal of molecular sciences, 2022-08, Vol.23 (16), p.8851

2022

Link zum Volltext

Verfügbarkeit prüfen

Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus

Metabolism, clinical and experimental, 2013-12, Vol.62 (12), p.1772-1778

2013

Link zum Volltext

Verfügbarkeit prüfen

Circadian‐timed quick‐release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus

Endocrinology, diabetes & metabolism, 2020-01, Vol.3 (1), p.e00101-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of insulin sensitivity measures in South Asians

Metabolism, clinical and experimental, 2013-10, Vol.62 (10), p.1448-1454

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of Bromocriptine-QR Therapy on Glycemic Control and Daily Insulin Requirement in Type 2 Diabetes Mellitus Subjects Whose Dysglycemia Is Poorly Controlled on High-Dose Insulin: A Pilot Study

Journal of Diabetes Research, 2015-01, Vol.2015, p.834903-7

2015

Link zum Volltext

Verfügbarkeit prüfen

A Problem in Gestation

The New England journal of medicine, 2011-09, Vol.365 (9), p.843-848

2011

Link zum Volltext

Verfügbarkeit prüfen

Preoperative A1C and Clinical Outcomes in Patients With Diabetes Undergoing Major Noncardiac Surgical Procedures

Diabetes care, 2014-03, Vol.37 (3), p.611-616

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of pre-diabetes on heart transplant outcomes in patients with advanced heart failure

The Journal of heart and lung transplantation, 2014-02, Vol.33 (2), p.215-217

2014

Link zum Volltext

Verfügbarkeit prüfen

Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus

Journal of Diabetes Research, 2015-01, Vol.2015, p.157698-13

2015

Link zum Volltext

Verfügbarkeit prüfen

A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II

Journal of hypertension, 2010-05, Vol.28 (5), p.1020-1026

2010

Link zum Volltext

Verfügbarkeit prüfen

Lysine-specific demethylase-1 modifies the age effect on blood pressure sensitivity to dietary salt intake

AGE, 2013-10, Vol.35 (5), p.1809-1820

2013

Link zum Volltext

Verfügbarkeit prüfen

1083-P: Bromocriptine-QR (BQR) Reduces Hypertriglyceridemia (HTG) in Hypertensive Type 2 Diabetes (T2D) Subjects

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Link zum Volltext

Verfügbarkeit prüfen

Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses

Journal of the renin-angiotensin-aldosterone system, 2011-12, Vol.12 (4), p.564-571

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin

Postgraduate medicine, 2017-05, Vol.129 (4), p.446-455

2017

Link zum Volltext

Verfügbarkeit prüfen

Inflammation and Hypertension: The Interplay of Interleukin-6, Dietary Sodium, and the Renin-Angiotensin System in Humans

American journal of hypertension, 2011-10, Vol.24 (10), p.1143-1148

2011

Link zum Volltext

Verfügbarkeit prüfen

TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH)

Diabetes care, 2018-03, Vol.41 (3), p.554-561

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 18968: Bromocriptine-QR: A Potential Novel Strategy for Cardiovascular Risk Reduction in Type 2 Diabetes

Circulation (New York, N.Y.), 2013-11, Vol.128 (suppl_22)

2013

Link zum Volltext

Verfügbarkeit prüfen

Response to comment on Underwood et al. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care 2014;37:611-616

Diabetes care, 2014-08, Vol.37 (8), p.e191-e191

2014

Link zum Volltext

Verfügbarkeit prüfen

Features and Prognosis of Exertional Syncope in Light-Chain Associated AL Cardiac Amyloidosis

The American journal of cardiology, 1997-11, Vol.80 (9), p.1242-1245

1997

Link zum Volltext

Verfügbarkeit prüfen

A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II

Journal of hypertension, 2010-05, Vol.28 (5), p.1020-1026

2010

Link zum Volltext

Verfügbarkeit prüfen

Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin

Postgraduate medicine, 2016-11, Vol.128 (8), p.761-769

2016

Link zum Volltext

Verfügbarkeit prüfen

1166-P: Bromocriptine-QR (BQR) Therapy Reduces Elevated Sympathetic Nervous System Activity (SNSA) and Oxidative Stress (OS) in Type 2 Diabetes (T2D) Subjects whose Dysglycemia Is Poorly Controlled on GLP-1 Receptor Agonist (GLP-1RA)

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Early Identification of Individuals with Poorly Controlled Diabetes Undergoing Elective Surgery: Improving A1C Testing in the Preoperative Period

Endocrine practice, 2015-03, Vol.21 (3), p.231-236

2015

Link zum Volltext

Verfügbarkeit prüfen

Predictors of plasma and urinary catecholamine levels in normotensive and hypertensive men and women

Journal of human hypertension, 2014-05, Vol.28 (5), p.292-297

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(28)
Humans
(27)
Female
(24)
Male
(20)
Middle Aged
(19)
Adult
(17)
Endocrinology & Metabolism
(14)
Biological And Medical Sciences
(12)
Blood Pressure
(10)
Diabetes
(10)
Hypertension
(10)
Medical Sciences
(10)
Aged
(9)
Bromocriptine
(7)
Cardiovascular System & Cardiology
(7)
Diabetes Mellitus, Type 2 - Drug Therapy
(7)
Insulin Resistance
(7)
Blood Glucose - Metabolism
(6)
Diabetes Mellitus
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects

Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus

Circadian‐timed quick‐release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus

Comparison of insulin sensitivity measures in South Asians

Impact of Bromocriptine-QR Therapy on Glycemic Control and Daily Insulin Requirement in Type 2 Diabetes Mellitus Subjects Whose Dysglycemia Is Poorly Controlled on High-Dose Insulin: A Pilot Study

The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes

A Problem in Gestation

Preoperative A1C and Clinical Outcomes in Patients With Diabetes Undergoing Major Noncardiac Surgical Procedures

Impact of pre-diabetes on heart transplant outcomes in patients with advanced heart failure

Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus

A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II

Lysine-specific demethylase-1 modifies the age effect on blood pressure sensitivity to dietary salt intake

1083-P: Bromocriptine-QR (BQR) Reduces Hypertriglyceridemia (HTG) in Hypertensive Type 2 Diabetes (T2D) Subjects

Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses

Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin

Inflammation and Hypertension: The Interplay of Interleukin-6, Dietary Sodium, and the Renin-Angiotensin System in Humans

TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH)

Abstract 18968: Bromocriptine-QR: A Potential Novel Strategy for Cardiovascular Risk Reduction in Type 2 Diabetes

Response to comment on Underwood et al. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care 2014;37:611-616

Features and Prognosis of Exertional Syncope in Light-Chain Associated AL Cardiac Amyloidosis

A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II

Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin

1166-P: Bromocriptine-QR (BQR) Therapy Reduces Elevated Sympathetic Nervous System Activity (SNSA) and Oxidative Stress (OS) in Type 2 Diabetes (T2D) Subjects whose Dysglycemia Is Poorly Controlled on GLP-1 Receptor Agonist (GLP-1RA)

Early Identification of Individuals with Poorly Controlled Diabetes Undergoing Elective Surgery: Improving A1C Testing in the Preoperative Period

Predictors of plasma and urinary catecholamine levels in normotensive and hypertensive men and women

Suchergebnisse filtern